Pharmacovigilance and outcomes: experience from Saudi Arabia narrative review

2024-9-3

Impact of adherence on the cost-effectiveness of apixaban and rivaroxaban in stroke prevention among patients with atrial fibrillation in the United States

2024-9-3

Value based healthcare and Health Technology Assessment for emerging market countries: joint efforts to overcome barriers

2024-9-2

Cost-effectiveness of atezolizumab plus Bevacizumab as first-line therapy for metastatic renal cell carcinoma

2024-8-30

Budget impact and cost per responder analysis of upadacitinib for the treatment of moderate to severe atopic dermatitis from the perspective of the social security and the private sector in Argentina

2024-8-23

Patients’ health related quality of life after massive weight loss reconstruction in the Netherlands

2024-8-19

Valuing quality of life for economic evaluations in cancer: navigating multiple methods

2024-8-19

Survival analysis of famotidine administration routes in non-traumatic intracerebral hemorrhage patients: based on the MIMIC-IV database

2024-8-18

Economic burden of suicides and suicide attempts in low- and middle-income countries: a systematic review of costing studies

2024-8-13

DIRECT HEALTHCARE COSTS for PEOPLE with CEREBRAL PALSY in the BRAZILIAN UNIFIED HEALTH SYSTEM BETWEEN 2015 and 2019

2024-8-13

Burden of non-motor symptoms of Parkinson’s disease: cost-of-illness and quality-of-life estimates through a scoping review

2024-8-13

The utility and impact of digital endpoints for improving breast cancer outcomes

2024-8-11

Cost-effectiveness analysis of tofacitinib for the treatment of moderate to severe rheumatoid arthritis: a systematic review and meta-analysis

2024-8-6

Public value judgments about the criteria for reimbursement of medicines in South Korea

2024-8-6

Next-generation sequencing in oncology: challenges in economic evaluations

2024-8-3

The cost-utility analysis of adding ocrelizumab to the treatment plan for primary progressive multiple sclerosis in Iran

2024-8-2

Usability of digital health devices in clinical trials

2024-7-30

Acceptability and willingness to pay for a hypothetical HIV vaccine in Brazil and the implications: a cross-sectional study

2024-7-25

Cost-effectiveness of dapagliflozin plus standard treatment compared to standard therapy for the management of chronic kidney disease in Colombia

2024-7-24

Cost of long-term care and balancing caregiver wellbeing: a narrative review

2024-7-20

Cost-effectiveness analysis of first-line serplulimab plus chemotherapy for advanced squamous non-small-cell lung cancer in China: based on the ASTRUM-004 trial

2024-7-15

Pembrolizumab combined with Chemotherapy versus placebo combined with Chemotherapy for HER2-negative advanced gastric cancer in China:A cost-effectiveness analysis

2024-7-9

Cost-effectiveness analysis of pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric/gastroesophageal junction cancer in the Chinese healthcare system

2024-7-9

Bridging the gap: enhancing medication adherence through research and innovation

2024-7-7

Mapping the World Health Organization Disability Assessment Scale 2.0 to the EQ-5D-5L in patients with mental disorders

2024-7-5

Adherence to oral anticoagulants in patients with non-valvular atrial fibrillation: the role of patients’ characteristics and out-of-pocket payments

2024-7-5

Engagement of medication users in the development and implementation of digital medication adherence technologies: a multi-stakeholder study

2024-7-1

How can physicians improve medication adherence and outcomes in dermatological conditions?

2024-6-24

Accounting for planetary boundaries in health economic evaluation

2024-6-21

Preferences of people with diabetes for diabetes care in Germany: a discrete choice experiment

2024-6-14

Pharmaceutical innovativeness index: methodological approach for assessing the value of medicines – a case study of oncology drugs

2024-6-13

Cost-effectiveness of a multicomponent-adherence intervention in fracture liaison services

2024-6-12

Leveraging sensor-based functional outcomes to enhance understanding of the patient experience: challenges and opportunities

2024-6-11

A cost-effectiveness analysis of reduced viral transmission with baloxavir marboxil versus oseltamivir or no treatment for seasonal and pandemic influenza management in the United Kingdom

2024-6-8

Video-based assessments of activities of daily living: generating real-world evidence in pediatric rare diseases

2024-6-7

Comparative efficacy of later-line therapies for metastatic colorectal cancer: a network meta-analysis of survival curves

2024-6-7

Multiple Sclerosis: Economic Burden, Therapeutic Advances, and Future Forecasts in the Middle East and North Africa Region

2024-6-7

Cost-effectiveness analysis comparing single-pill combination of perindopril/amlodipine/indapamide to the free equivalent combination in patients with hypertension from an Italian national health system perspective

2024-6-7

What are the costs of managing neck and low back pain in Brazil? Investigation of a ten-year period from the perspective of the Brazilian public health system

2024-6-5

Physician and patient adherence in hypertension trials: a point of view on an important issue to resolve

2024-6-5

The implications of cardiac device cybersecurity responsibilities and challenges faced by policymakers, manufacturers, and patients

2024-5-29

Cost-effectiveness analysis of atezolizumab plus bevacizumab compared with sorafenib as first-line treatment in advanced hepatocellular carcinoma in Singapore

2024-5-22

Economic evaluation of stereotactic radiotherapy and stereotactic radiosurgery technologies in the treatment of cancers: a systematic review

2024-5-20

Unlocking the full potential of digital endpoints for decision making: a novel modular evidence concept enabling re-use and advancing collaboration

2024-5-15

Quality-adjusted life years for HER2-positive, early-stage breast cancer using trastuzumab-containing regimens in the context of cost-effectiveness studies: a systematic review

2024-5-13

A Retrospective Budget Impact Analysis of Fidaxomicin Treatment for Clostridioides difficile Infections (CDI) in Germany

2024-5-9

A cost analysis of a simplified model for HCV screening and treatment at a tertiary hospital in Zimbabwe

2024-5-8

Informing evidence-based medicine for opioid use disorder using pharmacoeconomic studies

2024-5-2

Nonadherence to antiseizure medications: what have we learned and what can be done next?

2024-4-27

Cost effectiveness of hepatitis C direct acting agents

2024-4-26